Works matching IS 20726694 AND DT 2018 AND VI 10 AND IP 6
Results: 56
Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine Resistance.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 209, doi. 10.3390/cancers10060209
- By:
- Publication type:
- Article
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.
- Published in:
- 2018
- By:
- Publication type:
- Other
Innovative Technologies Changing Cancer Treatment.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 208, doi. 10.3390/cancers10060208
- By:
- Publication type:
- Article
Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 202, doi. 10.3390/cancers10060202
- By:
- Publication type:
- Article
Designer Oncolytic Adenovirus: Coming of Age.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 201, doi. 10.3390/cancers10060201
- By:
- Publication type:
- Article
Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 206, doi. 10.3390/cancers10060206
- By:
- Publication type:
- Article
Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 207, doi. 10.3390/cancers10060207
- By:
- Publication type:
- Article
Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 205, doi. 10.3390/cancers10060205
- By:
- Publication type:
- Article
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 204, doi. 10.3390/cancers10060204
- By:
- Publication type:
- Article
Overcoming Resistance of Human Non-Hodgkin’s Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 200, doi. 10.3390/cancers10060200
- By:
- Publication type:
- Article
TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 199, doi. 10.3390/cancers10060199
- By:
- Publication type:
- Article
Oncolytic Viruses for Multiple Myeloma Therapy.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 198, doi. 10.3390/cancers10060198
- By:
- Publication type:
- Article
Antiviral Drugs for EBV.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 197, doi. 10.3390/cancers10060197
- By:
- Publication type:
- Article
Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 196, doi. 10.3390/cancers10060196
- By:
- Publication type:
- Article
Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 195, doi. 10.3390/cancers10060195
- By:
- Publication type:
- Article
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 194, doi. 10.3390/cancers10060194
- By:
- Publication type:
- Article
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 193, doi. 10.3390/cancers10060193
- By:
- Publication type:
- Article
Recombinant TSR1 of ADAMTS5 Suppresses Melanoma Growth in Mice via an Anti-angiogenic Mechanism.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 192, doi. 10.3390/cancers10060192
- By:
- Publication type:
- Article
WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 191, doi. 10.3390/cancers10060191
- By:
- Publication type:
- Article
Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 190, doi. 10.3390/cancers10060190
- By:
- Publication type:
- Article
Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-to-Bone Metastasis.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 185, doi. 10.3390/cancers10060185
- By:
- Publication type:
- Article
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 184, doi. 10.3390/cancers10060184
- By:
- Publication type:
- Article
The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 189, doi. 10.3390/cancers10060189
- By:
- Publication type:
- Article
Regulation of Constitutive Interferon-Stimulated Genes (Isgs) in Tumor Cells Contributes to Enhanced Antitumor Response of Newcastle Disease Virus-Infected Tumor Vaccines.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 186, doi. 10.3390/cancers10060186
- By:
- Publication type:
- Article
Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 187, doi. 10.3390/cancers10060187
- By:
- Publication type:
- Article
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 188, doi. 10.3390/cancers10060188
- By:
- Publication type:
- Article
Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 183, doi. 10.3390/cancers10060183
- By:
- Publication type:
- Article
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 182, doi. 10.3390/cancers10060182
- By:
- Publication type:
- Article
The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 181, doi. 10.3390/cancers10060181
- By:
- Publication type:
- Article
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 175, doi. 10.3390/cancers10060175
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 179, doi. 10.3390/cancers10060179
- By:
- Publication type:
- Article
p53 and the Viral Connection: Back into the Future ‡.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 178, doi. 10.3390/cancers10060178
- By:
- Publication type:
- Article
Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 177, doi. 10.3390/cancers10060177
- By:
- Publication type:
- Article
Emerging and Established Models of Bone Metastasis.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 176, doi. 10.3390/cancers10060176
- By:
- Publication type:
- Article
KIAA0100 Modulates Cancer Cell Aggression Behavior of MDA-MB-231 through Microtubule and Heat Shock Proteins.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 180, doi. 10.3390/cancers10060180
- By:
- Publication type:
- Article
Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 174, doi. 10.3390/cancers10060174
- By:
- Publication type:
- Article
Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 171, doi. 10.3390/cancers10060171
- By:
- Publication type:
- Article
Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 166, doi. 10.3390/cancers10060166
- By:
- Publication type:
- Article
The Role of JMY in p53 Regulation.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 173, doi. 10.3390/cancers10060173
- By:
- Publication type:
- Article
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 172, doi. 10.3390/cancers10060172
- By:
- Publication type:
- Article
Clinical Importance of Epstein–Barr Virus-Associated Gastric Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 167, doi. 10.3390/cancers10060167
- By:
- Publication type:
- Article
The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 169, doi. 10.3390/cancers10060169
- By:
- Publication type:
- Article
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 170, doi. 10.3390/cancers10060170
- By:
- Publication type:
- Article
Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 165, doi. 10.3390/cancers10060165
- By:
- Publication type:
- Article
Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 164, doi. 10.3390/cancers10060164
- By:
- Publication type:
- Article
Epstein Barr Virus-Associated Hodgkin Lymphoma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 163, doi. 10.3390/cancers10060163
- By:
- Publication type:
- Article
p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 162, doi. 10.3390/cancers10060162
- By:
- Publication type:
- Article
KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 161, doi. 10.3390/cancers10060161
- By:
- Publication type:
- Article
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2018, v. 10, n. 6, p. 160, doi. 10.3390/cancers10060160
- By:
- Publication type:
- Article